The role of growth hormone/insulin-like growth factors in adipocyte differentiation

Metabolism

Volumn 44, Issue SUPPL. 4, 1995, Pages 45-49

  Wabitsch, Martin ^a,b   Hauner, Hans ^a,b   Heinze, Eberhard ^a,b   Teller, Walter M ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ADIPOCYTE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; STEM CELL;

ADIPOCYTES; ANIMAL; CELL DIFFERENTIATION; GROWTH HORMONE; HUMAN; INSULIN-LIKE GROWTH FACTOR I; STEM CELLS;

EID: 0029391352     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0026-0495(95)90220-1     Document Type: Article

References (58)

1. Mode of action of pituitary growth hormone on target cells
2. Insulin-like growth factors and their binding proteins
3. The insulin-like growth factors (IGF) of human serum: Chemical and biological characterization and aspects of their possible physiological role
4. Indirect actions of growth hormone
5. Effects of IGF/somatomedins on growth and differentiation of muscle and bone
6. An insulin-like growth factor binding protein enhances the biologic response to IGF-I
7. Insulin-like growth factor binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells
8. Reduction of plasma immunoreactive somatomedin C during fasting in humans
9. Insulin-like growth factors in the fed and fasted states
10. Effect of growth hormone on carbohydrate and lipid metabolism
11. Body fat in Laron syndrome patients: Effect of insulin-like growth factor I treatment
12. Subcutaneous adipose tissue and lipids in blood in growth hormone deficiency before and after treatment with human growth hormone
13. Exogenous human growth hormone reduces body fat in obese woman
14. Effects of growth hormone on body composition and metabolism
15. Evidence for a sensitive period in adipose cell replication in man
16. The growth of adipose tissue in children and adolescents
17. Cellularity of obese and nonobese human tissue
18. Studies of human adipose tissue
19. Adipose tissue cellularity in human obesity
20. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium
21. Sublines of mouse 3T3 cells that accumulate lipids
22. Establishment of preadipocyte clonal line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones
23. Cellular and molecular aspects of adipose tissue development
24. Growth hormone and the adipose conversion of 3T3 cells
25. Contribution of growth hormone to the adipogenic activity of serum
26. Adipogenic factors in human serum promote the adipose conversion of 3T3-L1 fibroblasts
27. Growth hormone regulation of the expression of differentiation-dependent genes in preadipocyte Ob 1771 cells
28. A dual effector theory of growth-hormone action
29. Growth hormone and adipose differentiation: Growth hormone-induced antimitogenic state in 3T3-F442A preadipocytes
30. Growth hormone-induced alteration of morphology and tubulin expression in 3T3 preadipose cells
31. Up-regulation of vinculin expression in 3T3 preadipose cell by growth hormone
32. Growth hormone stimulates c-fos gene expression by means of protein kinase C without increasing inositol lipid turnover
33. Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes
34. Acute regulation of insulin-like growth factor-I gene expression by growth hormone during adipose cell differentiation
35. The generation of insulin-like growth factor-I-sensitive cells by growth hormone action
36. The influence of human growth hormone on preadipocyte development in serum-supplemented and serum-free cultures of stromal-vascular cells from pig adipose tissue
37. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes
38. Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP
39. Development of a chemically defined, serum-free medium for differentiation of rat adipose precursor cells
40. Insulin-like growth factor-I induction of differentiation of porcine preadipocytes
41. Differentiation of adipocyte precursors in a serum-free medium is influenced by glucocorticoids and endogenously produced insulin-like growth factor-I
42. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue
43. Influence of somatotropin on lipid metabolism and IGF gene expression in porcine adipose tissue
44. Regulation of insulin-like growth factor-I ribonucleic acid expression, polypeptide secretion, and binding protein activity by growth hormone in porcine preadipocyte cultures
45. Insulinlike growth factor action and production in adipocytes and endothelial cells from human adipose tissue
46. Effects of human growth hormone on muscle and adipose tissue metabolism of the forearm of man
47. Effects of growth hormone on insulin action in man: Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization
48. In vitro effects of growth hormone in adipose tissue
49. Effects of growth hormone on glucose metabolism and glucose transport in 3T3-F442A cells: Dependence on cell differentiation
50. Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells
51. Characterization of the insulin and insulin-like growth factor receptors and responsivity of a fibroblast/adipocyte cell line before and after differentiation
52. Comparison of the delayed actions of growth hormone and somatomedin on adipose tissue metabolism
53. The lipolytic activity of low concentrations of insulin-like growth factors in ovine adipose tissue
54. Recombinant human insulin-like growth factor I (rhIGF-I) reduces hyperglycemia in patients with extreme insulin resistance
55. Insulinlike growth factor I improves glucose and lipid metabolism in type 2 diabetes mellitus
56. Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes
57. High dose intravenous, but not low dose subcutaneous, insulin-like growth factor-I therapy induces sustained insulin sensitivity in severely resistant type I diabetes mellitus